Ultrasound-guided Radiofrequency Ablation of Liver Metastasis in Two Cases with Neuroendocrine Tumors
Introduction: Theraputic modalities in patients with metastatic neuroendocrine tumors (NET), ineligible for radical surgery include somatostatin analogues, chemotherapy, biological therapy and local ablation or embolization of liver metastasis.
Aim(s): We report two cases with carcinoid syndrome and multiple neuroendocrine liver metastasis, treated with ultrasound-guided ablative therapy.
Materials and methods: Case 1 was a female, 61-years old, with lung NET and case 2- a female, aged of 47 years, with pancreatic NET.
Conference: 13th Annual ENETSConcerence (2016)
To read the full abstract, please log into your ENETS Member account.